<DOC>
	<DOC>NCT02538302</DOC>
	<brief_summary>Nocturnal enuresis is among the most common disorders in children. The aim of current study was to compare the efficacy and safety of Minirin and oxybutynin for treatment of nocturnal enuresis in children in Bandar Abbas in 2014.</brief_summary>
	<brief_title>Minirin Versus Oxybutynin for Nocturnal Enuresis in Children</brief_title>
	<detailed_description>Nocturnal enuresis is among the most common disorders in children. Several pharmacological and non-pharmacological treatments are available for nocturnal enuresis. Studies for reaching the best pharmacological treatment for this disorder are continuing. The aim of current study was to compare the efficacy and safety of Minirin and oxybutynin for treatment of nocturnal enuresis in children in Bandar Abbas in 2014.</detailed_description>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Nocturnal Enuresis</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>&gt;5 years old Nocturnal enuresis Candidate for pharmacological treatment Children who their parents did noted filled the informed consent form Impossibility of follow up during the study period History of seizure History of rheumatologic disorders such as sjogren's disease</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Minirin</keyword>
	<keyword>Oxybutynin</keyword>
	<keyword>Nocturnal enuresis</keyword>
</DOC>